NewsRoom Articles - Page 26 of 208

FridayAug 09, 2024 10:00 am

Australia Launches Novel Immunotherapy Program to Help Babies with Peanut Allergies

Australia recently launched a countrywide immunotherapy program for infants with peanut allergies. The program is a partnership between the Murdoch Children’s Research Institute and the country’s National Allergy Center of Excellence. This is the first time a countrywide program for peanut allergies is being integrated into mainstream care globally. The program, whose objective is to safely build tolerance and hopefully achieve remission, is available for babies under 12 months who have been diagnosed with peanut allergies. The infants must be under the care of an allergy specialist in one of the 10 public pediatric hospitals across the states taking part…

FridayAug 09, 2024 9:45 am

Astiva Health Inc. Focused on Establishing Lifelong Relationships, Providing Tailored Healthcare Approach to Underserved Populations

Survey indicates sizable proportion of older adult population copes with healthcare costs by skipping treatments, cutting back on basic and essential needs Astiva Health is keenly aware of problems faced by underserved senior population The company strives to bridge healthcare gaps through proactive, culturally responsive solutions As growing numbers of the U.S. population reach age 65, the challenge of adequate healthcare becomes even more critical. In fact, a West Health-Gallup survey reports that some elderly are forgoing needed care because of healthcare costs (https://ibn.fm/pJGqA). Astiva Health, a dynamic and innovative Medicare Advantage Prescription Drug (“MAPD”) health plan, is on a mission…

WednesdayAug 07, 2024 10:00 am

Snycio, Vevol Media Partner to Transform eCommerce Store Management

Recently, Syncio entered into a partnership agreement with Vevol Media to streamline e-commerce operations for businesses by integrating different sales channels. Syncio has, for a while now, been streamlining e-commerce operations for merchants on WooCommerce and Shopify. The company is focused on efficiency and simplicity, while Vevol Media specializes in assisting businesses to thrive in the digital marketplace. Vevol, a leading partner of Shopify, provides a comprehensive range of services, including Shopify design, development, support and marketing. This partnership is a huge step forward in the e-commerce space, combining Vevol’s Shopify expertise and Syncio’s synchronization tech. It will help deliver…

WednesdayAug 07, 2024 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids”

The report explores the growth, competition, and consumer trends, for lesser known cannabinoids The report highlights a 5.4% revenue increase in the edible market for 2023, with total sales reaching $2.097 billion As consumer preferences shift towards edibles for their therapeutic effects and consistent experiences, the industry product landscape is set to evolve With the increasing acceptance of cannabis use in society, the popularity of edibles—products containing cannabinoids that can be consumed as food or drink—has surged. While many consumers are familiar with edibles containing THC (tetrahydrocannabinol), known for its euphoric effects, or CBD (cannabidiol), recognized for its therapeutic benefits,…

TuesdayAug 06, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Advances Neurodegenerative Disease Treatment with Innovative Nanotherapeutics

Clene is developing a new class of drugs that hold the potential to transform the lives of millions suffering from debilitating conditions such as Amyotrophic Lateral Sclerosis (“ALS”), Multiple Sclerosis (“MS”), and Parkinson’s Disease (“PD”) CNM-Au8(R), Clene’s lead drug candidate, is a fundamentally new approach for treating the underlying factors contributing to ALS, MS, and PD, by restoring neuronal health and function ALS, the most prevalent adult-onset progressive motor neuron disease, affects approximately 30,000 people in the U.S. Clene (NASDAQ: CLNN), a pioneering biopharmaceutical company, is making significant strides in the treatment of neurodegenerative diseases through its novel nanotherapeutic platform.…

MondayAug 05, 2024 10:00 am

Study Uncovers How Brain Tumors Evolve During Treatment

Glioblastoma multiforme is one of the most common brain cancers, primarily affecting an individual’s spine and/or brain. This malignant tumor forms from astrocytes, which support nerve cells. These tumors usually grow and spread very quickly, which creates pressure and destroys healthy tissue. In 2008, the glioblastoma multiforme genome was characterized by the Cancer Genome Atlas. Since then, scientists have directed their efforts toward examining transcriptomic and genomic data for new therapeutic targets that will improve patient clinical outcomes. Despite this, the five-year survival rates for this aggressive cancer remain below 5%. In a new study, scientists recently demonstrated how brain…

FridayAug 02, 2024 10:00 am

Data Gaps Which Need to Be Filled in Medicare Advantage

All beneficiaries of Medicare can enroll in Medicare Advantage as an alternative if they need private insurance. Currently, Medicare Advantage makes up over one-half all individuals enrolled in Medicare. Estimates from the Center for American progress show that the Centers for Medicare and Medicaid Services overpays Medicare Advantage plans by between 22% to 39%. This year, overpayments total between $83 billion and $127 billion. This is despite the fact that there’s no substantial evidence that this program promotes health equity for its enrollees or enhances health-care quality. Considering this, there is need for the Centers for Medicare and Medicaid Services…

WednesdayJul 31, 2024 10:00 am

Study Shows Autism More Prevalent in Kids Living in Congested Areas

Cases of neurodevelopmental disorders have increased globally in the last couple of years, with countries such as Italy observing a significant increase in cases of autism, noting that the disorder is more than four times higher in males than females. Autism spectrum disorder affects how individuals interact with others, as well as how they behave, learn and communicate. This disorder is said to have multifactorial origins, with recognized environmental and genetic triggers. Researchers posit that the period between fetal life through early childhood is the most vulnerable time for neurodevelopmental disorders. They argue that during this period, exposure to neurotoxic…

TuesdayJul 30, 2024 9:45 am

Annovis Bio Inc. (NYSE: ANVS) Announces FDA Approval to Transition to New Form of Buntanetap for Future Clinical Trials

Annovis announced in June 2024 that they had filed a composition of matter patent for their new crystal form of buntanetap, along with a provisional patent for the manufacturing process The company’s goal is to use this technology to restore brain function and improve the quality of life for patients dealing with neurodegenerative disease such as Alzheimer’s disease The worldwide market for Alzheimer’s disease modifying drugs, versus symptomatic drugs, could approach $30 billion by 2030 Annovis Bio (NYSE: ANVS), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders like Alzheimer’s and Parkinson’s, just announced that the U.S.…

MondayJul 29, 2024 10:00 am

Researchers Identify New Gene Behind ALS Onset

Scientists have discovered a new mutation that may cause amyotrophic lateral sclerosis to develop. Amyotrophic lateral sclerosis, or ALS in short, is a neurodegenerative illness that weakens an individual’s muscles and affects their physical function. It starts by degenerating nerve cells in the brain and spinal cord, affecting an individual’s voluntary control of legs and arms. The illness leads to trouble breathing, swallowing and may cause slurred speech. The illness is rare, with an average incidence of 1.4 to 2.4 cases in every 100,000 individuals annually. Additionally, the illness, which is sometimes referred to as motor neuron disease, has no…